Abbreviations used: EDRF, endothelium-derived relaxing fac tor; GABA, ,),-aminobutyrate; LCGU, local cerebral glucose uti lization; MPTP, N-methyl-4-phenyl-I,2,3,6-tetrahydropyridine; NMDA, N-methyl-o-aspartate; PET, positron emission tomog raphy; SPECT, single photon emission computed tomography; rCBF, regional CBF.
presentations accepted can hardly be summarized in a few pages. One-page minipapers of these pre sentations selected by peer review have been pub lished in Supplement 1 to Volume 9 of this Journal.
The page numbers of the following references refer to this supplement. Four sessions were devoted to cerebrovascular diseases and stroke (the same num ber as devoted to the neuropsychological and psy chiatric correlates of cortical CBF and metabolism), as compared with nine sessions on experimental ischemia, nine on neuroimaging technology, nine on neurochemistry-neuropharmacology receptors and neurotransmitters. The aim of this overview is to attest to the fact that this scientific meeting has gradually become the international forum for pre sentation of recent progress in several areas of ap plied neurosciences rather than simply a club of sci entists devoted to the methodology and application of measurements of CBF and energy metabolism. To be coherent, the present brief synopsis (which re flects our personal taste at the meeting and does not do justice to a large number of excellent scientific works presented) analyzes 12 different subtopics that extend far beyond the original interests of the 1 All page numbers refer to Journal of Cerebral Blood Flow and Metabolism, Vo!' 9, Supp!. I, 1989 573 constituents of the Society. This growth undoubt edly reflects the enthusiasm of the new groups and many young investigators who have entered (and continue to enter) the field.
EXCITATORY AMINO ACIDS AND

MECHANISMS OF NEURONAL LOSS
The role of excitatory amino acid neurotransmit ters was emphasized in the process of ischemic neu ronal death as well as hypothesized in the patho physiology of various experimental brain injuries (S93, S286, S311) and in epilepsy. In particular, stimulation of N-methyl-D-aspartate (NMDA) re ceptors induces a long-lasting change in mitochon drial metabolism with specific and probably delete rious biochemical alterations (S301). Remarkable support for the hypothesis of selective vulnerability of limbic forebrain structures to excitotoxins was offered by the observation of patients who became ill after accidental ingestion of a glutamic acid ana logue (S517). Removal of the excitatory input to the hippocampal CAl region (S387) or administration of MK -801 (S306) reduces neuronal damage that fol lows ischemia or hypoglycemia and prevents devel opment of focal brain edema after brain injury (S77, S664).
Application of techniques not traditionally em
ployed in the field of CBF and metabolism, namely, immunocytochemistry and in situ hybridization, has uncovered aspects of the disturbed synthesis of brain proteins that occurs in CAl following ischemia (S 1, S 11) and has pointed to similarities in the bio chemical changes that follow both ischemia and sei zures. For instance, the heat shock protein, HSP70, is expressed in hippocampal neurons following isch emia (S 11) and kainate-induced status epileptic us (S228). Synthesis of neuropeptide Y increases in frontal cortex following kainate-induced seizures 574 EDITORIAL (S96) and in cerebrovascular sympathetic nerves following subarachnoid hemorrhage (S371).
EXPERIMENTAL EPILEPSY
The selective vulnerability of the hippocampus to seizures was stressed. Signs of cell damage are present after kainate-induced limbic seizures (S92) and following repeated full tonic-clonic convulsions induced by electroconvulsive shock treatment (S85). Evidence was provided of the involvement of excitatory amino acids in the development of neu ronal damage due to seizures (S8l, S95, S309).
However, the damage might be preceded by a high degree of mismatch between local cerebral glucose utilization (LCGU) and local CBF, which could re sult in the development of acidosis (S83, S233, S238) and calcium accumulation in cells (S92, S232). LCGU as defined by the e4C]2-deoxyglu cose method was measured in models of epilepsy in an attempt to define the structures involved in ini tiating and maintaining seizures. The findings of in creased glucose utilization in the hippocampus and deeply depressed metabolic rates in the cerebral cortex, which occur just after the termination of generalized seizures, were interpreted as indication for a role of the hippocampus in maintaining and probably terminating the seizures (S88). Limbic ar eas were reported to have a two-to threefold in crease in LCGU during development of pilocarpine induced seizures in the rat, suggesting that these areas are recruited before the activity spreads to most of the brain (S90). Epileptic activity, which follows withdrawal of local chronic infusion of -y-aminobutyrate (GABA), is reflected by an in crease in LCGU within the cortical focus and in the thalamic regions receiving cortical afferents results that indicate that the thalamus is likely to be the primary target of the epileptic focus (S94). quences of focal cerebral ischemia. Indeed, the use of these agents as pharmacological tools has shown that there is, in the rodent, a window of therapeutic opportunity of at least 3 h at which time drug ad ministration can still result in reduced neuronal damage (S298, S748).
EXPERIMENTAL CEREBRAL ISCHEMIA
A polyamine site has been associated with the NMDA receptor complex and it was shown that, with experimental ischemia, there is not only an activation of ornithine decarboxylase but also a marked increase in tissue concentration of at least one polyamine, putrescine (Sl9l, S279, S652). It is tempting to suppose that polyamines, acting syner gistically with glutamate, are of major importance in the ischemia-induced neuronal necrosis.
While the therapeutic benefits of NMDA antago nists, and especially of MK -80l, in experimental focal cerebral ischemia are unequivocal, the situa tion in global ischemia is most confused. Some studies are positive (S152, S171); others report no tissue saving (S744). In other investigations, posi tive results were associated with the energy status of the tissue (S6) or with the postischemic delay of administration (S558, S629). Thus, the importance of NMDA antagonism for the neurological and his tological recovery from global ischemia is a critical question that still has to be resolved.
The not inconsiderable neuroprotection obtained with NMDA antagonists alone has prompted some groups to combine this approach with other phar macological strategies to see if the tissue sparing cannot be even further enhanced. This is the case with NMDA blockade combined with calcium (S648), dopamine (S5), or muscarinic (S750) antag onists, all of which can enhance and even achieve near-maximal tissue protection. It is likely that, eventually, the clinical management of stroke will involve the administration of several pharmacolog ical agents.
The interest in the NMDA complex is not simply therapeutic. As the phencyclidine channel receptor is specifically exposed in pathological conditions, understanding of this receptor could shed light on basic questions such as drug kinetics in the isch emic brain and neuronal integrity following an isch emic insult (S182, S557, S745).
Though fewer than at previous biennial meetings, was consistent with intellectual deterioration (S21).
On the contrary, in patients with Wilson's disease metabolic alterations were found only in the stria� tum (S23). A general diffuse reduction of both CBF an� CMR0 2 was observed in patients with a mag netic resonance appearance of peri ventricular white matter lucencies (leukoaraiosis) in the absence of clinically apparent dementia syndromes (S569).
In the study of human brain tumors, the combi nation offluorodeoxyglucose PET and 31p magnetic resonance spectroscopy yields detailed and comple mentary information on basic metabolic processes.
Increased glucose metabolism in tumors did not lead to . tissue acidosis since pH, as measured by magnetic resonance spectroscopy, was in all in stances normal or even alkaline (S220).
A f�w studies confirmed the well-known finding of regwnal hypoperfusion and hypometabolism in partial epilepsy during the interictal phase and showed new data on the involvement of opiate (S60) and benzodiazepine (S230) receptors. PET and SPECT remain clinically helpful for detection of the epileptic focus in candidates for temporal lobe sur gery. The pathophysiology of classic and common migraine is another now-classic field for the use of functional neuroimaging modalities (S366, S719).
Frontal lobe CBF is decreased after cardiac ar rest (S363), during atrial fibrillation, and in subcor tical discrete lesions seen with multiple sclerosis (S741), whereas it is increased after cardioversion (S365).
CEREBROVASCULAR DISEASES AND STROKE
Cerebral vasoreactivity was tested with acetazol amide in patients with occlusive cerebrovascular diseases (S376) and correlated to transcranial Dop pler (S364). The clinical value of transcranial Dop pler was discussed in a special workshop. Magnetic resonance angiography showed positive prospects (S362). By using 31p nuclear magnetic resonance spe�troscopy, pH changes were investigated fol lowmg acute focal experimental ischemia (S357) and in patients after stroke (S361).
Emphasis is now placed on the early evaluation
